how are compounding pharmacies still selling semaglutide Pharmacy Semaglutide: Deep Dive Novo Nordisk's semaglutide shortage officially

At 26 weeks, participants receiving GLP-1 had a mean weight reduction of 8.6% to 12.6%, compared to a 2.0% reduction in the placebo group

They have a direct effect on egg quality, sperm quality and embryo viability

Hypoglycemia is not expected but has been reported, most often in patients who are also using agents known to cause hypoglycemia, such as insulin or sulfonylureas

Getting insurance to cover FDA-approved weight loss medications like Wegovy or Zepbound can be difficult

In most cases, there is no reason to discontinue GLP-1 treatment unless another specific medical indication arises

Mody RR, Meyer KL, Ward JM, ODay KB